Rhumbline Advisers »

Xtl Biopharmaceuticals shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Xtl Biopharmaceuticals (XTLB) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Xtl Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xtl Biopharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xtl Biopharmaceuticals by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $14k 6.0k 2.41

More positions owned by Rhumbline Advisers

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Berkshire Hathaway (BRK.B)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Exxon Mobil Corporation (XOM)
Visa (V)
Johnson & Johnson (JNJ)

View all positions for Rhumbline Advisers

Top funds holding Xtl Biopharmaceuticals

Noked Israel
SmartHarvest Portfolios
Rhumbline Advisers
GAMMA Investing
Morgan Stanley

View all funds holding Xtl Biopharmaceuticals